Protagonist Therapeutics Inc. – Investors and Politicians Who Own It
PTGX
Investors who own it
8 tracked investors, $1.8B in shares, each from their latest 13F.
| Investor | Value | Share of portfolio |
|---|---|---|
Farallon Capital ManagementQ2 2026 | $778.2M | 3.59% |
Rod WongRTW Investments, Q2 2026 | $620.4M | 5.30% |
Joseph EdelmanPerceptive Advisors, Q2 2026 | $120.4M | 1.81% |
Daniel SchneebergerADAR1 Capital Management, Q2 2026 | $117.8M | 5.39% |
Anand ParekhAlyeska Investment Group, Q2 2026 | $109M | 0.28% |
Stanley DruckenmillerDuquesne Family Office, Q2 2026 | $25.6M | 0.49% |
Polen CapitalQ2 2026 | $2.8M | 0.02% |
Ray DalioBridgewater Associates, Q2 2026 | $1.1M | 0.00% |
Politicians who own it
Estimated from annual disclosures and trades; values are rough estimates.
No member of Congress is estimated to hold this stock.
Investors buying and selling
| Investor | Action | Shares now |
|---|---|---|
| Farallon Capital Management | Added +0.4% | 6,196,006 |
| David Kroin | Reduced −47% | 1,715,691 |
| Daniel Schneeberger | Added +4.3% | 989,182 |
| Stanley Druckenmiller | New | 159,700 |
| Joseph Edelman | Reduced −4.1% | 1,030,134 |
| Mark Lampert | Reduced −20% | 2,560,916 |
| Polen Capital | Added +27% | 20,325 |
Politicians trading it
Latest Congress trades disclosed under the STOCK Act; amounts are ranges.
No disclosed Congress trades in this stock.